-
1
-
-
34447340514
-
Commentary: the ubiquity of prostate cancer: echoes of the past, implications for the present: "what has been will be again, what has been done will be done again; there is nothing new under the sun." ECCLESIASTES 1:9
-
doi:10.1093/ije/dym056
-
Thompson IM, Lucia MS, Tangen CM (2007) Commentary: the ubiquity of prostate cancer: echoes of the past, implications for the present: "what has been will be again, what has been done will be done again; there is nothing new under the sun." ECCLESIASTES 1: 9. Int J Epidemiol 36(2): 287-289. doi: 10. 1093/ije/dym056.
-
(2007)
Int J Epidemiol
, vol.36
, Issue.2
, pp. 287-289
-
-
Thompson, I.M.1
Lucia, M.S.2
Tangen, C.M.3
-
2
-
-
4644287961
-
Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study
-
doi:10.1093/jnci/djh259
-
Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC (2004) Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 96(18): 1358-1367. doi: 10. 1093/jnci/djh259.
-
(2004)
J Natl Cancer Inst
, vol.96
, Issue.18
, pp. 1358-1367
-
-
Potosky, A.L.1
Davis, W.W.2
Hoffman, R.M.3
Stanford, J.L.4
Stephenson, R.A.5
Penson, D.F.6
Harlan, L.C.7
-
3
-
-
69449098701
-
Estimation of absolute risk for prostate cancer using genetic markers and family history
-
doi:10.1002/pros.21002
-
Xu J, Sun J, Kader AK, Lindstrom S, Wiklund F, Hsu FC, Johansson JE, Zheng SL, Thomas G, Hayes RB, Kraft P, Hunter DJ, Chanock SJ, Isaacs WB, Gronberg H (2009) Estimation of absolute risk for prostate cancer using genetic markers and family history. Prostate 69(14): 1565-1572. doi: 10. 1002/pros. 21002.
-
(2009)
Prostate
, vol.69
, Issue.14
, pp. 1565-1572
-
-
Xu, J.1
Sun, J.2
Kader, A.K.3
Lindstrom, S.4
Wiklund, F.5
Hsu, F.C.6
Johansson, J.E.7
Zheng, S.L.8
Thomas, G.9
Hayes, R.B.10
Kraft, P.11
Hunter, D.J.12
Chanock, S.J.13
Isaacs, W.B.14
Gronberg, H.15
-
4
-
-
0026522840
-
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
-
Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, Fozard JL, Walsh PC (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267(16): 2215-2220.
-
(1992)
Jama
, vol.267
, Issue.16
, pp. 2215-2220
-
-
Carter, H.B.1
Pearson, J.D.2
Metter, E.J.3
Brant, L.J.4
Chan, D.W.5
Andres, R.6
Fozard, J.L.7
Walsh, P.C.8
-
5
-
-
0028905503
-
Prostate-specific antigen as predictor of prostate cancer in black men and white men
-
Whittemore AS, Lele C, Friedman GD, Stamey T, Vogelman JH, Orentreich N (1995) Prostate-specific antigen as predictor of prostate cancer in black men and white men. J Natl Cancer Inst 87(5): 354-360.
-
(1995)
J Natl Cancer Inst
, vol.87
, Issue.5
, pp. 354-360
-
-
Whittemore, A.S.1
Lele, C.2
Friedman, G.D.3
Stamey, T.4
Vogelman, J.H.5
Orentreich, N.6
-
6
-
-
0027972144
-
Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer
-
Stenman UH, Hakama M, Knekt P, Aromaa A, Teppo L, Leinonen J (1994) Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer. Lancet 344(8937): 1594-1598.
-
(1994)
Lancet
, vol.344
, Issue.8937
, pp. 1594-1598
-
-
Stenman, U.H.1
Hakama, M.2
Knekt, P.3
Aromaa, A.4
Teppo, L.5
Leinonen, J.6
-
7
-
-
0028801975
-
A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer
-
Gann PH, Hennekens CH, Stampfer MJ (1995) A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 273(4): 289-294.
-
(1995)
Jama
, vol.273
, Issue.4
, pp. 289-294
-
-
Gann, P.H.1
Hennekens, C.H.2
Stampfer, M.J.3
-
8
-
-
31844447749
-
Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C
-
doi:10.1373/clinchem.2005.050641
-
Ulmert D, Becker C, Nilsson JA, Piironen T, Bjork T, Hugosson J, Berglund G, Lilja H (2006) Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C. Clin Chem 52(2): 235-239. doi: 10. 1373/clinchem. 2005. 050641.
-
(2006)
Clin Chem
, vol.52
, Issue.2
, pp. 235-239
-
-
Ulmert, D.1
Becker, C.2
Nilsson, J.A.3
Piironen, T.4
Bjork, T.5
Hugosson, J.6
Berglund, G.7
Lilja, H.8
-
9
-
-
79952133146
-
Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50
-
doi:10.1002/cncr.25568
-
Lilja H, Cronin AM, Dahlin A, Manjer J, Nilsson PM, Eastham JA, Bjartell AS, Scardino PT, Ulmert D, Vickers AJ (2011) Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50. Cancer 117(6): 1210-1219. doi: 10. 1002/cncr. 25568.
-
(2011)
Cancer
, vol.117
, Issue.6
, pp. 1210-1219
-
-
Lilja, H.1
Cronin, A.M.2
Dahlin, A.3
Manjer, J.4
Nilsson, P.M.5
Eastham, J.A.6
Bjartell, A.S.7
Scardino, P.T.8
Ulmert, D.9
Vickers, A.J.10
-
10
-
-
77956811462
-
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study
-
doi:10.1136/bmj.c4521
-
Vickers AJ, Cronin AM, Bjork T, Manjer J, Nilsson PM, Dahlin A, Bjartell A, Scardino PT, Ulmert D, Lilja H (2010) Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study. BMJ (Clin Res Ed) 341: c4521. doi: 10. 1136/bmj. c4521.
-
(2010)
BMJ (Clin Res Ed)
, vol.341
-
-
Vickers, A.J.1
Cronin, A.M.2
Bjork, T.3
Manjer, J.4
Nilsson, P.M.5
Dahlin, A.6
Bjartell, A.7
Scardino, P.T.8
Ulmert, D.9
Lilja, H.10
-
11
-
-
63249118690
-
Screening and prostate-cancer mortality in a randomized European study
-
doi:10.1056/NEJMoa0810084
-
Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Maattanen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360(13): 1320-1328. doi: 10. 1056/NEJMoa0810084.
-
(2009)
N Engl J Med
, vol.360
, Issue.13
, pp. 1320-1328
-
-
Schroder, F.H.1
Hugosson, J.2
Roobol, M.J.3
Tammela, T.L.4
Ciatto, S.5
Nelen, V.6
Kwiatkowski, M.7
Lujan, M.8
Lilja, H.9
Zappa, M.10
Denis, L.J.11
Recker, F.12
Berenguer, A.13
Maattanen, L.14
Bangma, C.H.15
Aus, G.16
Villers, A.17
Rebillard, X.18
van der Kwast, T.19
Blijenberg, B.G.20
Moss, S.M.21
de Koning, H.J.22
Auvinen, A.23
more..
-
12
-
-
77955279420
-
Mortality results from the Goteborg randomised population-based prostate-cancer screening trial
-
doi:10.1016/s1470-2045(10)70146-7
-
Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, Pihl CG, Stranne J, Holmberg E, Lilja H (2010) Mortality results from the Goteborg randomised population-based prostate-cancer screening trial. Lancet Oncol 11(8): 725-732. doi: 10. 1016/s1470-2045(10)70146-7.
-
(2010)
Lancet Oncol
, vol.11
, Issue.8
, pp. 725-732
-
-
Hugosson, J.1
Carlsson, S.2
Aus, G.3
Bergdahl, S.4
Khatami, A.5
Lodding, P.6
Pihl, C.G.7
Stranne, J.8
Holmberg, E.9
Lilja, H.10
-
13
-
-
13844264517
-
Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/ml or less in a population-based screening setting? (ERSPC, section Rotterdam)
-
doi:10.1016/j.urology.2004.09.046
-
Roobol MJ, Roobol DW, Schroder FH (2005) Is additional testing necessary in men with prostate-specific antigen levels of 1. 0 ng/ml or less in a population-based screening setting? (ERSPC, section Rotterdam). Urology 65(2): 343-346. doi: 10. 1016/j. urology. 2004. 09. 046.
-
(2005)
Urology
, vol.65
, Issue.2
, pp. 343-346
-
-
Roobol, M.J.1
Roobol, D.W.2
Schroder, F.H.3
-
14
-
-
79952282237
-
Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam
-
doi:10.1016/j.eururo.2011.01.001
-
Bul M, van Leeuwen PJ, Zhu X, Schroder FH, Roobol MJ (2011) Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3. 0 ng/ml who are participating in ERSPC Rotterdam. Eur Urol 59(4): 498-505. doi: 10. 1016/j. eururo. 2011. 01. 001.
-
(2011)
Eur Urol
, vol.59
, Issue.4
, pp. 498-505
-
-
Bul, M.1
van Leeuwen, P.J.2
Zhu, X.3
Schroder, F.H.4
Roobol, M.J.5
-
15
-
-
78049479383
-
Balancing the harms and benefits of early detection of prostate cancer
-
doi:10.1002/cncr.25474
-
van Leeuwen PJ, Connolly D, Tammela TL, Auvinen A, Kranse R, Roobol MJ, Schroder FH, Gavin A (2010) Balancing the harms and benefits of early detection of prostate cancer. Cancer 116(20): 4857-4865. doi: 10. 1002/cncr. 25474.
-
(2010)
Cancer
, vol.116
, Issue.20
, pp. 4857-4865
-
-
van Leeuwen, P.J.1
Connolly, D.2
Tammela, T.L.3
Auvinen, A.4
Kranse, R.5
Roobol, M.J.6
Schroder, F.H.7
Gavin, A.8
-
16
-
-
47249150529
-
Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) study
-
doi:10.1002/ijc.23591
-
Ahn J, Moslehi R, Weinstein SJ, Snyder K, Virtamo J, Albanes D (2008) Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) study. Int J Cancer 123(5): 1154-1159. doi: 10. 1002/ijc. 23591.
-
(2008)
Int J Cancer
, vol.123
, Issue.5
, pp. 1154-1159
-
-
Ahn, J.1
Moslehi, R.2
Weinstein, S.J.3
Snyder, K.4
Virtamo, J.5
Albanes, D.6
-
17
-
-
77955309014
-
Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members
-
doi:10.1016/j.eururo.2010.02.002
-
Brandt A, Bermejo JL, Sundquist J, Hemminki K (2010) Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol 58(2): 275-280. doi: 10. 1016/j. eururo. 2010. 02. 002.
-
(2010)
Eur Urol
, vol.58
, Issue.2
, pp. 275-280
-
-
Brandt, A.1
Bermejo, J.L.2
Sundquist, J.3
Hemminki, K.4
-
18
-
-
40049098166
-
Cumulative association of five genetic variants with prostate cancer
-
doi:10.1056/NEJMoa075819
-
Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Balter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Gronberg H (2008) Cumulative association of five genetic variants with prostate cancer. N Engl J Med 358(9): 910-919. doi: 10. 1056/NEJMoa075819.
-
(2008)
N Engl J Med
, vol.358
, Issue.9
, pp. 910-919
-
-
Zheng, S.L.1
Sun, J.2
Wiklund, F.3
Smith, S.4
Stattin, P.5
Li, G.6
Adami, H.O.7
Hsu, F.C.8
Zhu, Y.9
Balter, K.10
Kader, A.K.11
Turner, A.R.12
Liu, W.13
Bleecker, E.R.14
Meyers, D.A.15
Duggan, D.16
Carpten, J.D.17
Chang, B.L.18
Isaacs, W.B.19
Xu, J.20
Gronberg, H.21
more..
|